main mill street investments, LLC

1508 olive street
paso robles, california 93446

NYS Entity Status
ACTIVE

NYS Filing Date
NOVEMBER 27, 2013

NYS DOS ID#
4493631

County
CLINTON

Jurisdiction
NEVADA

Registered Agent
NONE

NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY

Name History
2013 - MAIN MILL STREET INVESTMENTS, LLC









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Listing of the day: Water Mill, NY
    Monday May 1, 2017

    This Hamptons landmark home comes with a wealth of history and intrigue behind it.

    Source: The Wall Street Journal: Most Popular
  • Yogurt Declines Continue to Hurt General Mills
    Wednesday Jun 28, 2017

    General Mills’ new chief executive said he would invest in reviving sales as the struggling yogurt business continues to weigh on the company.

    Source: The Wall Street Journal: U.S. Business
  • Morrissey cancels Central Calif. show at last minute because of a broken onstage heater
    By Alyssa Pereira - Monday Nov 6, 2017

    Morrissey, a performer who has earned a reputation for frequently canceling shows last minute, canceled a show last minute Sunday night in Paso Robles, California.

    Source: SFGATE.com: Entertainment News
  • $10 Billion Robo-Adviser Betterment Flourishes as Chief Learns to Let Go
    Friday Sep 1, 2017

    Betterment LLC Chief Executive Jon Stein wants to use technology and automation to make investment advice and financial services broadly accessible while lowering the cost and removing compensation conflicts.

    Source: The Wall Street Journal: Technology: What's News
  • Mystery Woman
    Wednesday Nov 8, 2017

    Surveillance video of "Diana Ilic" meeting Chris Irons, an analyst with GeoInvesting LLC, before a dinner meeting at a suburban Philadelphia restaurant in July.

    Source: The Wall Street Journal: Most Popular
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy VC, Deals, & Startups Feed